Menu Search
Equities

Guangxi Wuzhou Zhongheng Group Co Ltd

600252:SHH

Guangxi Wuzhou Zhongheng Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)1.90
  • Today's Change-0.04 / -2.06%
  • Shares traded20.84m
  • 1 Year change-28.30%
  • Beta0.9948
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Guangxi Wuzhou Zhongheng Group Co Ltd grew revenues 14.10% from 2.71bn to 3.10bn while net income improved 6.69% from 79.03m to 84.31m.
Gross margin47.95%
Net profit margin0.81%
Operating margin1.93%
Return on assets0.21%
Return on equity0.28%
Return on investment0.34%
More ▼

Cash flow in CNYView more

In 2023, cash reserves at Guangxi Wuzhou Zhongheng Group Co Ltd fell by 699.25m. However, the company earned 403.03m from its operations for a Cash Flow Margin of 13.02%. In addition the company used 812.05m on investing activities and also paid 290.82m in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share1.87
Tangible book value per share1.66
More ▼

Balance sheet in CNYView more

Guangxi Wuzhou Zhongheng Group Co Ltd has a Debt to Total Capital ratio of 19.46%, a higher figure than the previous year's 9.07%.
Current ratio2.61
Quick ratio2.32
Total debt/total equity0.3066
Total debt/total capital0.1946
More ▼

Growth rates in CNY

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 8.18%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked below the industry average relative to its peers.
Div yield(5 year avg)1.22%
Div growth rate (5 year)-30.12%
Payout ratio (TTM)192.18%
EPS growth(5 years)-32.57
EPS (TTM) vs
TTM 1 year ago		-68.87
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.